• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AGN

ARGENICA THERAPEUTICS LIMITED

5.47% ! 67.5¢
Market Cap $86.46M  !

Argenica Therapeutics Limited is an Australia-based biotechnology company, developing... Argenica Therapeutics Limited is an Australia-based biotechnology company, developing novel therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. The Company's lead neuroprotective peptide candidate, ARG-007, has been demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischemic encephalopathy (HIE). The Company has initiated a Phase 2 clinical trial in acute ischemic stroke patients, as well as continuing to generate preclinical data in other neurological conditions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
AGN 00:10 24 8.5K
00:10 Last post  SpiralNotebook Comments Created with Sketch.  24  Views Created with Sketch.  8.5K 
AGN 26/04/25 94 23K
26/04/25 Last post  bavarian1975 Comments Created with Sketch.  94  Views Created with Sketch.  23K 
AGN 01/04/25 0 313
01/04/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  313 
AGN
Charting Thread
21/03/25 40 14K
21/03/25 Last post  MrLearner Comments Created with Sketch.  40  Views Created with Sketch.  14K 
AGN 21/03/25 0 342
21/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  342 
AGN
AGN Media thread
4 5 6
17/03/25 326 115K
17/03/25 Last post  Scottsmyname Comments Created with Sketch.  326  Views Created with Sketch.  115K 
AGN 06/03/25 15 4.6K
06/03/25 Last post  MrLearner Comments Created with Sketch.  15  Views Created with Sketch.  4.6K 
AGN 03/03/25 0 282
03/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  282 

See All Discussions arrow Created with Sketch.

Timeline

Last Patient Dosed in Phase 2 Stroke Trial
11 Apr 08:21
 
Notification of cessation of securities - AGN
01 Apr 17:01
 
Change of Share Registry Details
21 Mar 17:06
 
Investor Presentation
12 Mar 09:11
 
Final Director's Interest Notice
03 Mar 08:19
 
Non-Executive Director Resignation
03 Mar 08:19
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
67.5¢
Change
0.035(5.47%)
Mkt cap ! $86.46M
Open High Low Value Volume
67.5¢ 67.5¢ 67.5¢ $610 904

Buyers (Bids)

No. Vol. Price($)
1 1865 67.0¢
 

Sellers (Offers)

Price($) Vol. No.
69.0¢ 50000 1
View Market Depth
Last trade - 12.55pm 25/04/2025 (20 minute delay) ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.